Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MacroGenics Inc (NASDAQ:MGNX)

15.52
Delayed Data
As of Aug 18
 -0.31 / -1.96%
Today’s Change
14.36
Today|||52-Week Range
32.68
-24.07%
Year-to-Date

Today’s Trading

Previous close15.83
Today’s open15.67
Day’s range15.48 - 15.80
Volume283,898
Average volume (3 months)258,863
Market cap$571.1M
Dividend yield--
Data as of 3:59pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-168.25%
Earnings growth (this year)-154.49%
Earnings growth (next 5 years)--
Revenue growth (last year)-8.90%
P/E ratioNM
Price/Sales7.72
Price/Book2.01

Competitors

 Today’s
change
Today’s
% change
OTICOtonomy Inc-0.10-0.53%
SCLNSciClone Pharmaceuti...+0.05+0.45%
LCILannett Company Inc+0.55+3.64%
VSARVersartis Inc+0.10+0.61%
Data as of 4:01pm ET, 08/18/2017

Financials

Next reporting dateNovember 14, 2017
EPS forecast (this quarter)-$0.94
Annual revenue (last year)$91.9M
Annual profit (last year)-$58.5M
Net profit margin-63.70%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott E. Koenig
Chief Financial Officer, Secretary &
Senior VP
James Karrels
Corporate headquarters
Rockville, Maryland

Forecasts